SF002-96-1, a new drimane sesquiterpene lactone from an Aspergillus species, inhibits survivin expression
Open Access
- 13 December 2013
- journal article
- Published by Beilstein Institut in Beilstein Journal of Organic Chemistry
- Vol. 9 (1) , 2866-2876
Abstract
Survivin, a member of the IAP (inhibitor of apoptosis) gene family, is overexpressed in virtually all human cancers and is functionally involved in the inhibition of apoptosis, regulation of cell proliferation, metastasis and resistance to therapy. Because of its upregulation in malignancy, survivin has currently attracting considerable interest as a new target for anticancer therapy. In a screening of approximately 200 strains of imperfect fungi for the production of inhibitors of survivin promoter activity, a new drimane sesquiterpene lactone, SF002-96-1, was isolated from fermentations of an Aspergillus species. The compound inhibited survivin promoter activity in transiently transfected Colo 320 cells in a dose dependent manner with IC50 values of 3.42 µM (1.3 µg/mL). Moreover, it also reduced mRNA levels and protein synthesis of survivin and triggered apoptosis.Keywords
This publication has 39 references indexed in Scilit:
- The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosisNature Reviews Molecular Cell Biology, 2012
- Cell division control by the Chromosomal Passenger ComplexExperimental Cell Research, 2012
- Survivin expression and targeting in breast cancerSurgical Oncology, 2012
- Survivin: A Dual Player in Healthy and Diseased SkinJournal of Investigative Dermatology, 2012
- Survivin and IAP proteins in cell-death mechanismsBiochemical Journal, 2010
- Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer TherapeuticsClinical Cancer Research, 2008
- Survivin, cancer networks and pathway-directed drug discoveryNature Reviews Cancer, 2008
- Nuclear and Cytoplasmic Survivin: Molecular Mechanism, Prognostic, and Therapeutic PotentialCancer Research, 2007
- Survivin mediates targeting of the chromosomal passenger complex to the centromere and midbodyEMBO Reports, 2006
- Validating survivin as a cancer therapeutic targetNature Reviews Cancer, 2003